Earlier this month CSL Behring announced the availability of the next generation HeliTrax® System as part of a specially designed software platform for Apple’s iPhone®, iPod touch® or iPad™ devices. The enhanced system is designed to improve therapy management for people with hemophilia A who use CSL Behring’s recombinant factor VIII.
The new HeliTrax software is designed with an interface that ensures compatibility with both Lab Tracker™ and WebTracker™ patient management systems used by hemophilia treatment centers throughout the U.S. The software automatically transmits patient information to the hemophilia treatment centers, making management of the bleeding disorder easier for both users and staff. The interface was built in collaboration with the American Thrombosis and Hemostasis Network (ATHN), a nonprofit organization founded to advance and improve the care of individuals affected by bleeding and thrombotic disorders.
“The advancement of patient management is a priority that we share with hemophilia treatment centers. Our updates to HeliTrax will help meet that goal by improving data management and ease of user-provider communications,” said Garrett E. Bergman, MD, Senior Director of Medical Affairs, North America Commercial Operations at CSL Behring.
Source: CSL press release dated December 1, 2010
